Cistinexine
Cistinexine is a new expectorant agent. Cistinexine interacts with the complex form of RdRp. Cistinexine can be used in the study of chronic bronchitis. RdRp is involved in the replication and transcription of the SARS-CoV-2 genome[1][2].
Product Specifications
CAS Number
86042-50-4
UNSPSC
12352005
Target
SARS-CoV
Related Pathways
Anti-infection
Field of Research
Inflammation/Immunology
Smiles
CN(C1CCCCC1)CC2=C(C(Br)=CC(Br)=C2)NC([C@H](CSSC[C@H](NC(OCC3=CC=CC=C3)=O)C(NC4=C(C=C(Br)C=C4Br)CN(C5CCCCC5)C)=O)NC(OCC6=CC=CC=C6)=O)=O
Molecular Formula
C50H60Br4N6O6S2
Molecular Weight
1224.79
References & Citations
[1]Ahmad J, et al. SARS-CoV-2 RNA Dependent RNA polymerase (RdRp) - A drug repurposing study. Heliyon. 2020 Jul 23;6 (7) :e04502.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
